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 ABSTRACT 
 Objective  To investigate the long-term clinical and 
radiographic disease course of hand osteoarthritis (OA) 
and determinants of outcome. 
 Methods  Clinical and radiographic measures were 
obtained at baseline and after 6 years in 289 patients 
with hand OA (mean age 59.5 years, 83.0% women). 
Clinical outcomes were self-reported pain and functional 
limitations assessed with the Australian/Canadian 
Osteoarthritis Hand Index (AUSCAN). Poor clinical 
outcome was defi ned as a follow-up score not fulfi lling 
the Patient Acceptable Symptom State. Radiographic 
outcome was assessed by osteophytes and joint space 
narrowing (JSN) on standardised hand radiographs using 
the Osteoarthritis Research Society International (OARSI) 
atlas. Radiographic progression was defi ned as a change 
in osteophytes or JSN, above the smallest detectable 
change. Change in outcome measures was calculated 
and baseline determinants for poor clinical outcome and 
radiographic progression were assessed using logistic 
regression analysis. 
 Results  Clinical change showed great variation, with 
half of the population reporting deterioration. Poor 
outcome in pain was related to high levels of functional 
limitations and a high number of painful joints at baseline. 
Poor outcome on functional limitations was related to 
high baseline pain levels. Radiographic progression was 
present in 52.5% of patients and associated with high 
baseline levels of pain, nodes, osteophytes and the 
presence of erosive OA and nodal OA. Clinical change and 
radiographic progression were not related. 
 Conclusions  This study gives insight in the clinical and 
radiographic course of hand OA as well as determinants 
of outcome. These fi ndings enable better patient 
information on prognosis. The relationship between 
clinical and radiographic outcome needs further 
investigation. 
 INTRODUCTION 
 Osteoarthritis (OA) is a common musculoskeletal 
disorder characterised by degradation of cartilage 
and changes in subchondral bone leading to pain 
and disability. The hand is a frequently involved 
joint site.  1    2  The prevalence of symptomatic hand 
OA is estimated to be as high as 26% in women 
over 70 years of age.  3  It is therefore a burden for the 
individual and for society, increasing in relevance 
with an ageing population.  3    4  Treatment options 
are limited to patient education and symptom 
alleviation. 
 Despite its high prevalence and disease burden, 
little is known about the natural history of hand 
OA and the determinants of outcome. Knowledge 
of these topics enables the clinician to provide the 
patient with a more accurate prognosis and infor-
mation about the disease. From a scientifi c point of 
view insight in the disease course and risk factors 
for an unfavourable outcome may reveal modifi -
able factors and thus enable the development of 
new therapies, including much desired structure 
modifying treatments. 
 Studies investigating the course of hand OA in 
patient populations are scarce.  5  –  8  Previously, we 
reported on the course of hand OA over a period 
of 2 years, showing that a considerable proportion 
of patients showed clinical as well as radiographic 
deterioration over this relatively short period.  8  Since 
hand OA is a chronic disease and data on its long-
term course and outcome are lacking, we assessed 
the clinical and radiographic disease course of hand 
OA over a period of 6 years as well as determinants 
of poor clinical outcome and radiographic progres-
sion in a cohort of patients with hand OA. In addi-
tion, we assessed if changes in clinical symptoms 
are related to radiographic progression. 
 PATIENTS AND METHODS 
 Study design and patient population 
 The ‘Genetics ARthrosis and Progression’ (GARP) 
study is a cohort study aimed at identifying deter-
minants of OA susceptibility and progression. The 
study population comprises 192 Caucasian sibling 
pairs with symptomatic OA at multiple sites in the 
hand or in at least 2 of the following sites: hand, 
knee, hip or spine. Patients were recruited from 
rheumatologists, orthopaedic surgeons and general 
practitioners. Further details about the recruitment 
and selection have been published elsewhere.  9  The 
GARP study was approved by the relevant Medical 
Ethics Committee. 
 Patients were included for baseline assessment 
between August 2000 and March 2003. From April 
2007 to June 2008 participants who consented for a 
follow-up evaluation were assessed. All consenters 
completed questionnaires and part of them visited 
the outpatient clinic for physical examination and 
radiographic evaluation. 
 Patients were eligible for the present study if they 
had hand OA defi ned according to the American 
College of Rheumatology criteria for clinical hand 
OA  10  or if structural abnormalities were present. 
Structural abnormalities were defi ned as the pres-
ence of radiographic hand OA based on a Kellgren–
Lawrence score of ≥2 in at least one interphalangeal 
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used to visualise change in these measures. To evaluate the 
proportion of patients with clinically relevant change in pain 
and functional limitations, the minimum clinically impor-
tant improvement (MCII) of 1.49 and 1.25, respectively, was 
used.  16  Those with a change on AUSCAN pain and functional 
limitations below −1.49 and −1.25, respectively, were classi-
fi ed as improved. Patients with change on AUSCAN pain and 
functional limitations above 1.49 and 1.25, respectively, were 
classifi ed as deteriorated. For osteophytes and JSN the small-
est detectable change (SDC) was used to assess change above 
measurement error.  17  The SDC was 1.3 for osteophytes and 
1.5 for JSN. 
 Poor clinical outcome was defi ned as AUSCAN pain and 
 functional limitation scores at follow-up above the Patient 
Acceptable Symptom State, which were 8.2 and 16.1, 
 respectively.  18  Generalised estimating equation (GEE) models 
were used to estimate the risk for poor clinical outcome after 6 
years for tertiles of baseline determinants with robust variance 
estimators to account for family effects within sibling pairs. 
Adjustments were made for baseline tertiles of AUSCAN pain 
and functional limitations depending on the outcome and for 
follow-up time. 
 Radiographic progression was defi ned as a change in osteo-
phytes or JSN above the SDC. The risk for radiographic progres-
sion was estimated for tertiles of baseline determinants using 
GEE analysis to account for family effects within sibling pairs. 
Corrections were made for tertiles of baseline osteophyte and 
JSN scores and follow-up time. 
 ORs were subsequently transformed to risk ratios (RRs) using 
the approximation formula described by Zhang and Yu because 
ORs for common outcomes in a fi xed cohort are not good 
approximations of RRs.  19  
 The association between change in symptoms and 
 radiographic progression was assessed by estimating mean 
 differences of change on AUSCAN pain and functional limi-
tations between patients with and without radiographic pro-
gression using linear mixed models. Adjustments were made 
for age, sex, BMI, baseline AUSCAN, baseline osteophytes, 
baseline JSN, follow-up time and family effects within sibling 
pairs. 
 RESULTS 
 Study population 
 Of the 357 patients with hand OA at baseline 300 (84.0%) con-
sented to participate in the follow-up study of whom 242 com-
pleted questionnaires and visited the outpatient clinic and 58 
completed questionnaires only. Consent was not given by 43 
(12.0%) patients, 12 (3.3%) were deceased and 2 (0.6%) were 
lost to follow-up. Most frequent reasons for non-consent were 
loss of interest (n=13), health problems not related to OA (n=7), 
unavailability of transport (n=7) and emigration (n=2). Of the 
300 eligible patients complete clinical or radiographic follow-up 
data were available in 289 patients. These patients were included 
in the present study. Of these 289 patients, 18 had no baseline 
AUSCAN due to delayed validation of the Dutch AUSCAN. Of 
the 242 patients visiting the outpatient clinic, 6 had incomplete 
data due to  missing radiographs. 
 The mean follow-up time was 6.1 years (range 5.0–7.8 years). 
Baseline characteristics are shown in  table 1 . Patients not 
included were somewhat older. Other demographic character-
istic as well as disease characteristics did not differ between 
these groups (data not shown). Looking at hand OA subsets, 22 
patients had erosive OA and thumb base OA comprising 52.4% 
(IP) or fi rst carpometacarpal (CMC-1) joint, or the presence of at 
least two Heberden or Bouchard nodes. 
 Clinical outcome 
 Self-reported hand pain and functional limitations were assessed 
with the pain (fi ve items) and physical functioning (nine items) 
subscales of the Australian/Canadian Osteoarthritis Hand Index, 
Likert form 3.0 (AUSCAN LK 3.0).  11  On this hand-specifi c ques-
tionnaire items are rated from 0 (none) to 4 (extreme) using a 
48-h timeframe. Higher scores indicate worse pain and more 
functional limitations. 
 Radiographic outcome 
 Hand radiographs (dorsal–volar) were obtained at baseline and 
follow-up by a single radiographer, employing a standard proto-
col with a fi xed fi lm focus distance (1.15 m). Radiographs were 
scored paired in chronological order blinded for patient char-
acteristics by consensus opinion of two experienced readers 
(JB, IW) using the Osteoarthritis Research Society International 
(OARSI) atlas.  12  Osteophytes and joint space narrowing (JSN) 
were graded 0–3 in the distal interphalangeal (DIP), proximal 
interphalangeal (PIP), fi rst interphalangeal (IP-1), CMC-1, meta-
carpophalangeal (MCP) and scaphotrapezotrapezoidal (STT) 
joints with total scores ranging from 0 to 96. Intraclass correla-
tion coeffi cients for intrareader reproducibility based on 25 ran-
domly selected pairs of radiographs were 0.94 for osteophytes 
and 0.87 for JSN. 
 Determinants of outcome 
 All determinants were measured at baseline. Demographic 
variables were age, sex, body mass index (BMI) and postmeno-
pausal status. 
 Clinical determinants were pain and functional limitations 
measured with the AUSCAN, pain intensity score and the 
number of self-reported painful joints. The pain intensity score 
was obtained by grading pain on joint pressure from 0 to 3 
in 30 hand joints (0=no pain, 1=with pain, 2=with pain and 
wincing, 3=with pain, wincing and withdrawal of joint). The 
number of painful joints was obtained using a standard dia-
gram including 30 hand joints on which the patient marked 
the joints where pain was experienced on most days of the 
preceding month. 
 Determinants refl ecting structural abnormalities were osteo-
phytes, JSN and the number of nodes in IP joints plus CMC-1 
squaring. The latter was assessed by joint palpation. 
 In addition, three proposed hand OA subsets were evalu-
ated as outcome determinants.  13  Erosive OA was defi ned as 
the presence of erosive radiographic features according to the 
Verbruggen–Veys score in at least two IP joints.  14  Nodal OA was 
defi ned as the presence of Heberden or Bouchard nodes affect-
ing at least two rays of either hand.  15  The last subset comprises 
symptomatic thumb base OA, which was defi ned as the pres-
ence of pain or stiffness in the CMC-1 joint on most of the days 
of the preceding month. 
 The use of medication for OA joint symptoms at baseline 
and follow-up and hand surgery performed over the follow-up 
period were recorded. 
 Statistical analysis 
 Data were analysed using SPSS V.16.0 (SPSS, Chicago, 
Illinois, USA). Mean changes with 95% CI for AUSCAN 
pain, AUSCAN functional limitations, osteophyte and JSN 
scores were calculated. Cumulative probability plots were 
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 Determinants of poor clinical outcome in hand OA after 6 years 
 Poor outcome in pain was related to high levels of functional 
limitations and a high number of painful joints at baseline ( table 
4 ). More pain at baseline, refl ected by AUSCAN pain and the 
number of painful joints, was associated with a higher risk of 
poor outcome in functional limitations. Determinants refl ecting 
structural abnormalities, demographic characteristics (data not 
shown) and hand OA subsets were not associated with poor 
clinical outcome. Adjustment for medication use or hand sur-
gery did not substantially infl uence the estimates. 
 Determinants of radiographic progression of hand OA over 6 
years 
 Demographic characteristics were not related to radiographic 
progression (data not shown). Of the clinical variables, high lev-
els of self-reported pain and pain intensity were associated with 
a higher risk of radiographic progression, whereas self-reported 
functional limitations were not ( table 5 ). A high number of 
nodes and osteophyte scores were also related to radiographic 
progression. Patients with erosive OA had a higher risk of radio-
graphic progression than patients with non-erosive OA. Nodal 
OA was associated with a two times higher risk of radiographic 
progression. Correction for medication use or hand surgery did 
not change these results. 
 Relationship between clinical change and radiographic 
progression in hand OA 
 The mean change in self-reported pain and functional limita-
tions was not different between patients with and without 
radiographic progression, with adjusted mean differences (95% 
CI) of −0.14 (−1.21, 0.92) and −0.57 (2.36, 1.22) for pain and 
functional limitations, respectively. This means that clinical 
change and radiographic progression are not related. 
 DISCUSSION 
 This study is the fi rst to assess the long-term course of symp-
toms and radiographic abnormalities in patients with hand OA 
and determinants of poor outcome. In contrast to the ongoing 
radiographic progression, clinically, deterioration and improve-
ment were observed. Poor clinical outcome after 6 years was 
associated with high levels of pain and functional limitations at 
baseline. More pain, structural abnormalities and the presence 
of erosive OA and nodal OA were associated with a higher risk 
of radiographic progression over 6 years. Change in symptoms 
and radiographic progression were not related. These fi ndings 
give insight in the long-term disease course of hand OA and fac-
tors associated with poor outcome. As a consequence the clini-
cian can provide the patient with more accurate information on 
prognosis. From a scientifi c point of view these fi ndings imply 
that the clinical and radiographic course of hand OA are distinct, 
making development of structure modifying treatments with 
clinical benefi t challenging. 
and 16.2% of the patients with erosive OA and thumb base OA, 
respectively. 
 Clinical course of hand OA over 6 years 
 The mean increase in self-reported pain was small ( table 2 ). 
However, there was great variation on the individual level as 
shown in  fi gure 1A . An increase in pain was present in 109 
patients (40.2%) whereas 71 patients (26.2%) reported less pain. 
The same was found for change in functional limitations: 136 
patients (50.2%) patients reported more functional limitations 
and 71 patients (26.2%) improved ( fi gure 1A ). 
 At baseline and follow-up 137 (47.4%) and 157 (54.3%) 
patients used medication for joint symptoms, respectively. Non-
steroidal anti-infl ammatory drugs and paracetamol were most 
frequently used: at baseline by 67.2% and 52.6%, respectively 
and at follow-up by 45.2% and 75.2%, respectively. Hand sur-
gery was performed in 46 (15.9%) patients, comprising mostly 
of surgery for carpal tunnel syndrome and in 4 cases of joint 
surgery. 
 Radiographic course of hand OA over 6 years 
 Osteophyte and JSN scores increased over time ( table 2 ). 
Progression of osteophytes and JSN was present in 106 (44.9%) 
and 61 (25.8%) patients, respectively ( fi gure 1B ). In 124 (52.5%) 
patients radiographic progression, defi ned as progression in 
osteophytes or JSN, was present. Most change was seen in the 
DIP joints followed by the PIP joints and CMC-1 joints ( table 3 ). 
 Table 1  Baseline characteristics of 289 patients with hand 
osteoarthritis (OA) 
 Characteristic  
Age, years  59.5 (7.4)
Women, n (%) 240 (83.0)
Postmenopausal women, n (%) 220 (91.6)
Time after menopause, years  12.1 (8.4)
Body mass index, kg/m 2  27.0 (4.7)
ACR criteria hand OA, n (%) 226 (78.2)
Right handed, n (%) 232 (80.3)
Hand OA subsets:
Erosive OA, n (%)  42 (14.5)
 Age, years  60.0 (7.5)
 Women, n (%)  35 (83)
Nodal OA, n (%) 205 (70.7)
 Age, years  59.5 (7.6)
 Women, n (%) 180 (88)
Thumb base OA, n (%) 136 (47.1)
 Age, years  58.9 (7.2)
 Women, n (%) 124 (91)
Additional OA sites, n (%):
Knee OA  92 (31.8)
Hip OA  64 (22.1)
Spine OA 232 (80.3)
 Values are means (SD) unless stated otherwise. 
 Table 2  Baseline, follow-up and change scores on self-reported pain and functional limitations (n=271), 
osteophytes and joint space narrowing (n=236) in patients with hand osteoarthritis followed for 6 years. 
 
 Baseline  Follow-up 
 Mean change (95% CI)  Mean (SD)  Median (IQR)  Mean (SD)  Median (IQR) 
Self-reported pain (0–20)  6.7 (4.8)  7.0 (3.0–10.0)  7.4 (4.9)  7.0 (4.0–11.0) 0.7 (0.3 to 1.2)
Self-reported function (0–36) 11.8 (8.9) 10.0 (4.0–19.0) 13.9 (8.9) 13.0 (7.0–21.0) 2.1 (1.3 to 2.9)
Osteophytes (0–96) 10.7 (8.2)  9.0 (5.0–14.0) 12.5 (9.4) 10.0 (6.0–16.0) 1.8 (1.6 to 2.1)
Joint space narrowing (0–96) 19.1 (11.3) 18.0 (12.0–24.0) 20.1 (11.8) 19.0 (12.3–25.0) 1.1 (0.8 to 1.3)
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proportions reported over a 2-year period in the GARP study.  8  
Our fi ndings are in line with a study by Dieppe  et al who found 
that around half of the population reported worse overall OA 
condition over 3 and 8 years, whereas about a quarter improved 
over both periods.  20  Allen  et al showed that the average change 
on AUSCAN scores over 4 years was small, but again almost 
half of the individuals reported worse hand symptoms.  21  It 
seems that the evolution of clinical symptoms is heterogeneous. 
Furthermore, the proportion of patients who deteriorate and 
improve does not differ much in the short and long term. This 
may be due to adaptation to a chronic condition over time or 
other psychosocial factors rather than genuine improvement of 
the disease. The follow-up assessment took place at an arbitrary 
time point. The change may therefore not refl ect the evolution 
of the disease over the whole time period, although on average 
it is valid. 
 The radiographic course of hand OA has been studied more 
extensively, but still the number of studies is limited. Most stud-
ies have been conducted in samples from the general popula-
tion. In our patient sample we found that 52.5% of patients had 
radiographic progression: 44.9% had progression of osteophytes 
and 25.9% had progression of JSN. A study over 10 years found 
that 90% and 74% of patients with hand OA had progression of 
osteophytes and JSN, respectively.  6  These studies illustrate that 
the radiographic course of hand OA is an ongoing process. 
 There are a number of potential limitations to this study. The 
fi rst concerns the possibility of bias due to differences between 
 Very few studies report on the clinical course of hand OA. 
We found that over a period of 6 years 40% to 50% of patients 
experienced more pain and functional limitations whereas 
about a quarter improved. These proportions are similar to the 
 Figure 1   Cumulative probability plots of change in self-reported pain and functional limitations, osteophytes and joint space narrowing (JSN) in 
patients with hand osteoarthritis over a 6-year period. A. Change in self-reported pain and functional limitations. The dotted lines represent the cut-off 
for deterioration and improvement based on the minimum clinically important improvement. Patients above the upper dotted line have deterioration of 
pain or functional limitations. Patients below the lower dotted line have improvement of pain or functional limitations. B. Change in osteophytes and 
JSN. All patients above the dotted smallest detectable change (SDC) line are classifi ed as having progression in osteophytes or JSN. 
 Table 3  Distribution of changes in osteophytes and joint space 
narrowing of the hand over 6 years in 236 patients with hand 
osteoarthritis 
  ≤−2  −1  0  1  2  3  4  ≥5 
Osteophytes
 DIP joints 0 3 160 41 15 9 4 4
 PIP joints 0 0 169 44 12 4 3 4
 IP-1 joints 0 1 186 44 5 0 0 0
 CMC-1 joints 0 2 169 50 11 5 0 0
 MCP joints 0 2 215 13 4 2 0 0
 STT joints 0 1 229 6 0 0 0 0
Joint space narrowing
 DIP joints 2 8 173 33 11 4 5 0
 PIP joints 3 2 207 11 7 2 1 3
 IP-1 joints 0 3 204 19 9 1 0 0
 CMC-1 joints 4 6 184 32 10 0 0 0
 MCP joints 0 0 219 11 3 2 0 1
 STT joints 0 1 208 21 5 1 0 0
 Values represent the number of patients with corresponding change for each hand joint 
group. 
 CMC-1, fi rst carpometacarpal joints; DIP, distal interphalangeal joints; IP-1, fi rst 
interphalangeal joint; MCP, metacarpophalangeal joints; PIP, proximal interphalangeal 
joints; STT, scaphotrapezotrapezoidal joints. 
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have shown that clinical improvement is seen in a substantial 
proportion of patients and some of the patients remain stable, 
even over a long time period. Thus, clinical deterioration is not 
inevitable for each patient. In contrast, radiographic abnormali-
ties will worsen over time. It is important to bear in mind and 
inform patients that the evolution of symptoms and radio-
graphic abnormalities are not related. With respect to patient 
prognosis, this study highlights parameters that are easy to 
obtain in order to identify patients at risk for poor outcome. 
If patients report high levels of pain and functional limitations 
at presentation they are at risk to have poor outcome on pain 
and functional limitations in the long term. The same is true 
for patients with more than eight painful joints. Patients with 
high levels of symptoms at presentation, nodal OA, erosive 
OA or a considerable amount of osteophytes are most likely to 
show progression of radiographic signs of OA. Since symptoms 
are most important to patients and predictive for clinical and 
radiographic outcome of hand OA, they are of greater value 
in the evaluation of patients with hand OA than radiographic 
OA signs. 
 We found that change in symptoms was not related to struc-
tural changes. This discordance, for hand OA and for OA in gen-
eral, has been known well from cross-sectional studies and to 
lesser extent from longitudinal studies.  8    22  This has important 
implications for the development of structure modifying treat-
ments. Since symptomatic hand OA is considered the disease 
consenters and non-consenters. However, demographic and dis-
ease characteristics did not differ between these groups, except 
for a higher age of non-consenters. We expect that this age dif-
ference has no effect on the study outcome, since age was not 
associated with any of the outcomes. Radiographic follow-up 
data were not available in all patients since a proportion only 
completed questionnaires. However, baseline radiographic 
scores did not differ between those with and without complete 
data indicating that selection bias is probably absent. Third, our 
sample consists of patients with familial OA at multiple sites. 
Whether the results can be generalised to patients with other 
hand OA phenotypes has to be investigated. Another issue 
concerns the use of the MCII as cut-off for improvement and, 
conversely, for deterioration on the AUSCAN. This was used 
because there are no cut-offs available for clinically relevant 
deterioration on the AUSCAN. Finally, we used a self-reported 
outcome measure for functioning because performance mea-
sures were not available. Since performance is thought to refl ect 
other aspects of functioning it would be interesting to investi-
gate the evolution of hand performance over time as well as 
determinants of outcome. 
 To date, the only information the clinician could provide 
patients with hand OA was that their condition would deterio-
rate over time. At what pace and what the chances for worsen-
ing of the disease are, was unknown. This study enables more 
accurate information on the disease course and prognosis. We 
 Table 4  Risk of poor clinical outcome of hand osteoarthritis on self-reported pain and functional limitations defi ned as not fulfi lling the Patient 
Acceptable Symptom State after 6 years, for tertiles of baseline determinants and hand osteoarthritis subsets 
 
 Poor outcome 
pain (n=271) 
 Risk ratio (95% CI) 
 Poor outcome 
function (n=271) 
 Risk ratio (95% CI) 
 Crude  Adjusted*  Crude  Adjusted* 
Self-reported pain
 <4 10/76 1 1  9/76 1 1
 4–8 34/98 2.64 (1.56 to 3.97) 2.57 (1.50 to 3.91) 28/98 2.41 (1.34 to 3.87) 1.38 (0.57 to 2.93)
 >8 73/97 5.72 (4.38 to 6.63) 5.74 (4.38 to 6.65) 71/97 6.18 (4.69 to 7.23) 3.56 (1.63 to 5.83)
Self-reported function
 <7 14/89 1 1 10/89 1 1
 7–16 41/98 2.66 (1.68 to 3.75) 1.60 (0.80 to 2.79) 33/98 3.00 (1.64 to 4.74) 2.97 (1.61 to 4.72)
 >16 62/84 4.69 (3.63 to 5.45) 2.57 (1.26 to 4.13) 65/84 6.89 (5.31 to 7.90) 6.88 (5.30 to 7.90)
No. of painful joints
 <4 19/93 1 1 18/93 1 1
 4–8 37/89 2.03 (1.33 to 2.82) 1.43 (0.79 to 2.31) 30/89 1.74 (1.09 to 2.54) 1.39 (0.75 to 2.28)
 >8 61/89 3.36 (2.62 to 3.94) 2.11 (1.25 to 3.08) 60/89 3.48 (2.69 to 4.12) 2.39 (1.47 to 3.37)
Pain intensity
 <1 20/80 1 1 18/80 1 1
 1–4 39/101 1.55 (1.01 to 2.17) 0.92 (0.47 to 1.60) 34/101 1.50 (0.92 to 2.20) 0.83 (0.39 to 1.58)
 >4 58/90 2.58 (1.98 to 3.08) 1.24 (0.68 to 1.99) 56/90 2.76 (2.05 to 3.38) 1.46 (0.77 to 2.37)
No. of nodes
 <6 26/86 1 1 25/86 1 1
 6–11 45/98 1.52 (1.03 to 2.04) 1.29 (0.75 to 1.91) 43/98 1.51 (1.02 to 2.04) 1.06 (0.59 to 1.72)
 >11 46/87 1.75 (1.22 to 2.26) 1.44 (0.91 to 2.02) 40/87 1.58 (1.07 to 2.12) 0.98 (0.56 to 1.57)
Osteophytes
 <6 29/84 1 1 31/84 1 1
 6–11 37/95 1.13 (0.76 to 1.54) 0.93 (0.59 to 1.36) 35/95 1.00 (0.66 to 1.39) 0.75 (0.43 to 1.21)
 >11 48/89 1.56 (1.14 to 1.97) 1.22 (0.77 to 1.73) 40/89 1.22 (0.83 to 1.62) 0.72 (0.40 to 1.19)
JSN
 <14 36/89 1 1 35/89 1 1
 14–22 33/92 0.88 (0.59 to 1.24) 0.72 (0.42 to 1.12) 32/92 0.88 (0.57 to 1.25) 0.59 (0.32 to 1.01)
 >22 45/87 1.28 (0.93 to 1.62) 1.02 (0.64 to 1.46) 39/87 1.14 (0.79 to 1.51) 0.79 (0.45 to 1.23)
Hand OA subsets
 Erosive hand OA 23/37 1.58 (1.13 to 1.96) 1.12 (0.56 to 1.73) 21/37 1.54 (1.10 to 1.95) 1.14 (0.75 to 1.59)
 Nodal hand OA 92/191 1.54 (1.10 to 1.99) 1.25 (0.82 to 1.74) 81/191 1.26 (0.87 to 1.68) 0.80 (0.46 to 1.29)
 Thumb base OA 68/125 1.62 (1.24 to 1.99) 0.92 (0.56 to 1.38) 71/125 2.24 (1.69 to 2.76) 1.50 (0.95 to 2.15)
 *Adjusted for baseline scores of the clinical outcome measure, follow-up time and family effects. 
 JSN, joint space narrowing; OA, osteoarthritis. 
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Rijnland Hospital, Leiderdorp: Dr EJ van Langelaan) and referring rheumatologists, 
orthopaedic surgeons and general practitioners. 
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of clinical and public health interest, it is desirable if these 
treatments infl uence symptoms and not just structural abnor-
malities.  23  These data show that change in symptoms does not 
coincide with change in structure. Whether the explanation is 
that there is really no association or that the current outcome 
measures are not sensitive enough is unknown, warranting 
more research. 
 In conclusion, this study gives insight in the long-term clini-
cal and radiographic disease course of hand OA as well as in 
determinants of poor outcome. This enables more accurate 
patient information on prognosis. It also shows that the clinical 
and radiographic course of hand OA is distinct, making devel-
opment of structure modifying treatments challenging. Further 
research on prognostic factors in hand OA is needed to confi rm 
and extend our fi ndings as well as research on the relationship 
between change in symptoms and structural abnormalities. 
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 Table 5  Risk of radiographic progression of hand osteoarthritis over 





 Risk ratio (95% CI) 
 Crude  Adjusted* 
Self-reported pain    
 <4 23/60 1 1
 4–8 38/78 1.27 (0.86 to 1.69) 1.28 (0.84 to 1.74)
 >8 50/80 1.63 (1.21 to 1.99) 1.62 (1.14 to 2.02)
Self-reported function
 <7 33/76 1 1
 7–16 38/75 1.17 (0.80 to 1.52) 1.23 (0.85 to 1.60)
 >16 40/67 1.37 (1.00 to 1.71) 1.33 (0.95 to 1.73)
No. of painful joints
 <4 30/78 1 1
 4–8 48/76 1.64 (1.24 to 1.98) 1.63 (1.19 to 2.00)
 >8 46/82 1.46 (1.05 to 1.84) 1.34 (0.90 to 1.77)
Pain intensity
 <1 24/72 1 1
 1–4 56/90 1.87 (1.39 to 2.28) 1.80 (1.31 to 2.24)
 >4 44/74 1.78 (1.28 to 2.23) 1.70 (1.18 to 2.19)
No. of nodes
 <6 22/79 1 1
 6–11 51/78 2.35 (1.80 to 2.81) 2.06 (1.47 to 2.60)
 >11 51/79 2.32 (1.71 to 2.81) 1.84 (1.19 to 2.48)
Osteophytes
 <6 27/71 1 1
 6–11 40/87 1.21 (0.83 to 1.61) 1.28 (0.87 to 1.70)
 >11 57/78 1.92 (1.51 to 2.22) 1.86 (1.38 to 2.21)
JSN
 <14 38/75 1 1
 14–22 33/86 0.74 (0.47 to 1.06) 0.71 (0.45 to 1.05)
 >22 53/75 1.47 (1.10 to 1.78) 1.24 (0.82 to 1.63)
Hand OA subsets
 Erosive hand OA 30/35 1.83 (1.50 to 2.01) 1.55 (1.04 to 1.88)
 Nodal hand OA 104/164 2.28 (1.74 to 2.74) 1.94 (1.37 to 2.48)
 Thumb base OA 64/109 1.18 (0.96 to 1.36) 1.16 (0.91 to 1.36)
 *Adjusted for baseline osteophyte and joint space narrowing scores, follow-up time and 
family effects. 
 JSN, joint space narrowing; OA, osteoarthritis. 
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